中国伤残医学2017，Vol.25Issue(12)：14-16,3.DOI:10.13214/j.cnki.cjotadm.2017.12.008
骨化三醇联合骨肽治疗老年性骨质疏松症的疗效观察
Therapeutic effect of ossylated triol combined with bone peptide onsenile osteoporosis
陈国政 1黄婷 1梁健 1陈瑜 1梁增章1
作者信息
- 1. 广东湛江廉江市人民医院,广东 廉江 524400
- 折叠
摘要
Abstract
Objective:To study the value of ossylated triol combined with osteopeptide in elderly patients with osteoporosis.Methods:: 70 cases of senile osteoporosis were selected from 2014 to 2016.The patients were randomly divided into observation group and control group.The patients were treated with calcitriol in the control group, and the patients in the observation group Calcitriol combined with bone peptide treatment, compared the two groups of clinical efficacy.Results:s: The total effective rate of clinical treatment was 94.29% in the observation group, which was significantly higher than that in the control group (71.43%).There was significant difference between the two groups (P <0.05).Conclusion: The effect of calcitriol combined with bone peptide in the treatment of senile osteoporosis is remarkable, which is widely popularized in clinical practice.关键词
老年性骨质疏松症/骨化三醇联合骨肽/临床效果Key words
senile osteoporosis/calcitriol combined with bone peptide/clinical effect分类
医药卫生引用本文复制引用
陈国政,黄婷,梁健,陈瑜,梁增章..骨化三醇联合骨肽治疗老年性骨质疏松症的疗效观察[J].中国伤残医学,2017,25(12):14-16,3.
